In September 2024, a message on the Bedfordshire trust website said 11,000 patients needed to be re-tested.
It warned some of them could have been misdiagnosed with type 2 diabetes as a result of problems with tests analysed at the hospital's laboratory.
The trust apologised "for any emotional distress and inconvenience".
In July 2025, the Medicines and Healthcare products Regulatory Agency said it had received reports describing a positive bias delivered by the Trinity Biotech machines.
This resulted in some patients being incorrectly diagnosed as pre-diabetic or diabetic.
